Review of Acadia Pharmaceuticals: guarding the central nervous system

Acadia Pharmaceuticals (NASDAQ: ACAD) — pharmaceutical company from the USA, which is engaged in research in the field of neurobiology. The main field of activity is the development of drugs to alleviate the condition of patients with severe neurological diseases: Parkinson's disease, schizophrenia and dementia.